Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1950 1
1951 1
1953 1
1959 2
1960 2
1962 2
1963 1
1964 3
1965 1
1969 1
1970 2
1971 1
1972 2
1973 1
1974 4
1975 4
1976 2
1977 4
1978 5
1979 9
1980 7
1981 4
1982 2
1983 2
1984 1
1986 2
1987 4
1988 7
1989 3
1990 7
1991 9
1992 4
1993 11
1994 8
1995 4
1996 8
1997 10
1998 10
1999 11
2000 8
2001 6
2002 19
2003 15
2004 16
2005 26
2006 31
2007 36
2008 41
2009 39
2010 38
2011 49
2012 57
2013 47
2014 44
2015 36
2016 41
2017 36
2018 33
2019 43
2020 55
2021 74
2022 61
2023 65
2024 71
2025 49

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,061 results

Results by year

Filters applied: . Clear all
Page 1
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation.
Kumar A, Soumerai J, Abramson JS, Barnes JA, Caron P, Chhabra S, Chabowska M, Dogan A, Falchi L, Grieve C, Haydu JE, Johnson PC, Joseph A, Kelly HE, Labarre A, Lue JK, Martignetti R, Mi J, Moskowitz A, Owens C, Plummer S, Puccio M, Salles G, Seshan V, Simkins E, Slupe N, Zhang H, Zelenetz AD. Kumar A, et al. Among authors: owens c. Blood. 2025 Jan 30;145(5):497-507. doi: 10.1182/blood.2024025563. Blood. 2025. PMID: 39437708 Free PMC article. Clinical Trial.
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.
Moskowitz AJ, Shah G, Schöder H, Ganesan N, Drill E, Hancock H, Davey T, Perez L, Ryu S, Sohail S, Santarosa A, Galasso N, Neuman R, Liotta B, Blouin W, Kumar A, Lahoud O, Batlevi CL, Hamlin P, Straus DJ, Rodriguez-Rivera I, Owens C, Caron P, Intlekofer AM, Hamilton A, Horwitz SM, Falchi L, Joffe E, Johnson W, Lee C, Palomba ML, Noy A, Matasar MJ, Pongas G, Salles G, Vardhana S, Sanin BW, von Keudell G, Yahalom J, Dogan A, Zelenetz AD, Moskowitz CH. Moskowitz AJ, et al. Among authors: owens c. J Clin Oncol. 2021 Oct 1;39(28):3109-3117. doi: 10.1200/JCO.21.01056. Epub 2021 Jun 25. J Clin Oncol. 2021. PMID: 34170745 Free PMC article. Clinical Trial.
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
Lee CH, Voss MH, Carlo MI, Chen YB, Zucker M, Knezevic A, Lefkowitz RA, Shapnik N, Dadoun C, Reznik E, Shah NJ, Owens CN, McHugh DJ, Aggen DH, Laccetti AL, Kotecha R, Feldman DR, Motzer RJ. Lee CH, et al. Among authors: owens cn. J Clin Oncol. 2022 Jul 20;40(21):2333-2341. doi: 10.1200/JCO.21.01944. Epub 2022 Mar 17. J Clin Oncol. 2022. PMID: 35298296 Free PMC article. Clinical Trial.
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation.
Kharbanda RK, Kennedy J, Jamal Z, Dodd M, Evans R, Bal KK, Perkins AD, Blackman DJ, Hildick-Smith D, Banning AP, Baumbach A, Ludman P, Palmer S, Stables RH, Henderson R, Appleby C, Cotton J, Curzen N, Ozkor M, Byrne J, Aggarwal R, Das R, Doshi S, Watkins S, Muir DF, Anderson R, Chowdhary S, Varcoe R, Dorman S, Firoozi S, Chelliah R, Owens C, Redwood S, Prendergast B, Iqbal J, Ratib K, Dospinescu C, Suresh V, Cruden N, Rajathurai T, Malik IS, Wiper A, Costopoulos C, Khurana A, Banning A, Clayton T; BHF PROTECT-TAVI Investigators. Kharbanda RK, et al. Among authors: owens c. N Engl J Med. 2025 Jun 26;392(24):2403-2412. doi: 10.1056/NEJMoa2415120. Epub 2025 Mar 30. N Engl J Med. 2025. PMID: 40162661 Clinical Trial.
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
Batlevi CL, Sha F, Alperovich A, Ni A, Smith K, Ying Z, Soumerai JD, Caron PC, Falchi L, Hamilton A, Hamlin PA, Horwitz SM, Joffe E, Kumar A, Matasar MJ, Moskowitz AJ, Moskowitz CH, Noy A, Owens C, Palomba LM, Straus D, von Keudell G, Zelenetz AD, Seshan VE, Younes A. Batlevi CL, et al. Among authors: owens c. Blood Cancer J. 2020 Jul 17;10(7):74. doi: 10.1038/s41408-020-00340-z. Blood Cancer J. 2020. PMID: 32678074 Free PMC article.
Neurovascular coupling, functional connectivity, and cerebrovascular endothelial extracellular vesicles as biomarkers of mild cognitive impairment.
Owens CD, Pinto CB, Mukli P, Gulej R, Velez FS, Detwiler S, Olay L, Hoffmeister JR, Szarvas Z, Muranyi M, Peterfi A, Pinaffi-Langley ACDC, Adams C, Sharps J, Kaposzta Z, Prodan CI, Kirkpatrick AC, Tarantini S, Csiszar A, Ungvari Z, Olson AL, Li G, Balasubramanian P, Galvan V, Bauer A, Smith ZA, Dasari TW, Whitehead S, Medapti MR, Elahi FM, Thanou A, Yabluchanskiy A. Owens CD, et al. Alzheimers Dement. 2024 Aug;20(8):5590-5606. doi: 10.1002/alz.14072. Epub 2024 Jul 3. Alzheimers Dement. 2024. PMID: 38958537 Free PMC article.
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Anderton J, Moroz V, Marec-Bérard P, Gaspar N, Laurence V, Martín-Broto J, Sastre A, Gelderblom H, Owens C, Kaiser S, Fernández-Pinto M, Fenwick N, Evans A, Strauss S, Whelan J, Wheatley K, Brennan B. Anderton J, et al. Among authors: owens c. Trials. 2020 Jan 17;21(1):96. doi: 10.1186/s13063-019-4026-8. Trials. 2020. PMID: 31952545 Free PMC article.
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Ladenstein R, et al. Among authors: owens c. Lancet Oncol. 2018 Dec;19(12):1617-1629. doi: 10.1016/S1470-2045(18)30578-3. Epub 2018 Nov 12. Lancet Oncol. 2018. PMID: 30442501 Clinical Trial.
1,061 results